Eupraxia Pharmaceuticals Inc.
$6.67
-0.69 (-9.31%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +1.9%
- 3 Months
- -5.9%
- YTD
- -11.6%
- 1 Year
- +26.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 62.4%
- Largest decline max drawdown, since Aug 2025
- -35.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.68
Own EPRX?
See how EPRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.